Drug
Granisetron clinical trials
Also written Kytril and Sancuso.
- studies test it
- 62
- open now
- 4
- in phase 3
- 14
- first study started
- 1996
Keep track of what changes. Save the Granisetron studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
56 studies that test it; most in 2018 (6)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 15
- Phase 3
- 14
- Phase 4
- 17
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
- Nausea
- 14
Who runs them
Industry 20 · Other 42
Assiut University (6) · Kyowa Kirin Co., Ltd. (5) · Ain Shams University (2) · Teva Pharmaceuticals USA (2) · Roxane Laboratories (2) · LG Life Sciences (2) · Kyowa Kirin Pharmaceutical Development Ltd (2) · University of Colorado, Denver (1)
Often tested with
Tested in the same studies.
Ondansetron (8) · Palonosetron (5) · Dexamethasone (4) · Metoclopramide (4) · Aprepitant (4) · Meperidine (2) · Dolasetron (2) · Cyclophosphamide (2)
Studies
Open first, then newest update. How each study uses Granisetron is read from its arms, and is right about nine times in ten.
Testing it · 62
- Granisetron Combined With Dexamethasone or Metoclopramide for PONV Prevention After Laparoscopic CholecystectomyNot yet recruitingPhase 4Assiut UniversityNCT07360431Written as Granisetron
- Intravenous Granisetron Vs Dexmedetomidine on Postspinal in the Cesarean Section.Enrolling by invitationNot applicableMinia UniversityNCT06762860Written as Granisetron
- Comparative Study Between Intravenous Granisetron and Ondansetron on Their Effect on Hemodynamics and Shivering After Spinal Anesthesia in Elective Cesarean DeliveryRecruitingNot applicableSohag UniversityNCT06437236Written as granisetron
- Clonidine Versus Granisetron for Shivering PrevensionRecruitingPhase 2Zagazig UniversityNCT06031090Written as Granisetron Injection
- Cisplatin Disposition and Kidney InjuryActive, not recruitingPhase 3University of Colorado, DenverNCT03817970Written as Granisetron
- Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular DisordersActive, not recruitingPhase 4Mansoura UniversityNCT07401745Written as Granisetron
- Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)CompletedPhase 4Helsinn Healthcare SANCT04817189Written as Granisetron, 2 mg (oral) or 1 mg (IV) OR Palonosetron, 0.5 mg (oral), 0.25mg (IV) OR Ondansetron, 16 mg (oral) or 8 mg (IV) OR Dolasetron 100 mg (oral) OR Tropisetron 5 mg (oral or IV)
- Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean SectionsCompletedPhase 4Ain Shams UniversityNCT06513806Written as Granisetron 1 Mg/mL Intravenous Solution
- Postoperative Intraperitoneal Pain Management Following Laparoscopic CholecystectomyCompletedPhase 3Future University in EgyptNCT06281418Written as Granisetron 1 Mg/mL Intravenous Solution
- Granisetron 1 mg Tablets, Non-fastingCompletedPhase 1Teva Pharmaceuticals USANCT00834522Written as Granisetron hydrochloride 1 mg tablets
- Granisetron 1 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00834717Written as Granisetron hydrochloride 1 mg tablets
- Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 YearsWithdrawnPhase 1Kyowa Kirin Pharmaceutical Development LtdNCT01596426Written as Sancuso
- Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 YearsWithdrawnPhase 1Kyowa Kirin Pharmaceutical Development LtdNCT01596413Written as Sancuso
- An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal GranisetronCompletedPhase 1Kyowa Kirin Co., Ltd.NCT00868764Written as granisetron
- Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)CompletedPhase 1Kyowa Kirin Co., Ltd.NCT00890565Written as granisetron
- Effect of External Heat on a Transdermal Granisetron Patch in Pharmacokinetics (PK) of Healthy SubjectsCompletedPhase 1Kyowa Kirin Co., Ltd.NCT01073696Written as granisetron IV
- To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV)CompletedPhase 3Kyowa Kirin Co., Ltd.NCT00273468Written as Granisetron
- PK, Tolerability and Safety of the Co-administration of Sancuso® (Transdermal Granisetron) and IV GranisetronCompletedPhase 1Kyowa Kirin Co., Ltd.NCT00873197Written as granisetron
- Granisetron Versus Ondansetron for Nausea and Vomiting in Pediatric Age GroupCompletedNot applicableAin Shams UniversityNCT06175806Written as Granisetron Oral Liquid Product
- Palonosetron vs Combination of Granisetron and Dexamethasone in Preventing PONV in Laparoscopic Cholecystectomy.CompletedPhase 4Universiti Kebangsaan Malaysia Medical CentreNCT06043336Written as Dexamethasone, granisetron & palonosetron
See all 62 studies that test Granisetron →
Given in every arm · 12 — Granisetron is usual care beside what is tested
- E7 TCR T Cells for Human Papillomavirus-Associated CancersCompletedPhase 1/2National Cancer Institute (NCI)NCT02858310Written as Granisetron
- The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After LaryngectomyCompletedNot applicableEye & ENT Hospital of Fudan UniversityNCT06000137Written as Granisetron Injection
- Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner PatientsStatus unknownNot applicableShanghai Children's Medical CenterNCT04873284Written as Granisetron plus dexamethasone
- Aromatherapy for Prevention of Intrathecal Morphine Induced Nausea and VomitingCompletedNot applicableUniversiti Kebangsaan Malaysia Medical CentreNCT03434340Written as Granisetron
- Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced CancerCompletedPhase 1AstraZenecaNCT03333824Written as Kytril (granisetron)
- Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHDCompletedPhase 2Stanford UniversityNCT00186628Written as Granisetron
- Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)CompletedPhase 3Merck Sharp & Dohme LLCNCT00952341Written as granisetron
- Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic ChemotherapyCompletedPhase 3Tesaro, Inc.NCT01499849Written as Granisetron
- Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic ChemotherapyCompletedPhase 3Tesaro, Inc.NCT01500226Written as Granisetron
- Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic ChemotherapyCompletedPhase 3Tesaro, Inc.NCT01500213Written as Granisetron
- The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic ChemotherapyCompletedPhase 2Jiangsu Simcere Pharmaceutical Co., Ltd.NCT01909856Written as Granisetron
- R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell LymphomaCompletedPhase 2University of MiamiNCT00450801Written as Granisetron
As the comparator · 10 — what is tested is compared with Granisetron
- Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCCNot yet recruitingPhase 3Guangxi Medical UniversityNCT05711823Written as Granisetron and dexamethasone
- A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine SurgeryCompletedPhase 4University of MalayaNCT06540885Written as Granisetron (Group G)
- Staccato® Granisetron Single Dose PKCompletedPhase 1Nova Pneuma Inc.NCT04200092Written as IV Granisetron 1mg
- Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 YearsCompletedPhase 1Kyowa Kirin Pharmaceutical Development LtdNCT01596400Written as Granisetron IV
- A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and VomitingCompletedPhase 3Solasia Pharma K.K.NCT01937156Written as Granisetron Hydrochloride Tablet
- A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and NauseaCompletedPhase 3Astellas Pharma IncNCT00272285Written as Granisetron
- Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy VolunteersCompletedPhase 1Maxinase Life Sciences Ltd.NCT02563951Written as Kytril 1mg (IV injection)
- Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic ChemotherapyCompletedPhase 3Taiho Pharmaceutical Co., Ltd.NCT00359567Written as granisetron hydrochloride
- AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic ProgenitorsCompletedPhase 4PETHEMA FoundationNCT00415103Written as Granisetron
- An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer PatientsCompletedPhase 2Xijing HospitalNCT00666783Written as Granisetron
Codes
What other systems call Granisetron · ClinicalTrials.gg INT008616
- MeSH (NLM) D017829GranisetronConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) WZG3J2MCOLGRANISETRONConfirmed FDA, Wikidata
- RxNorm 26237Confirmed FDA, Wikidata
- Wikidata Q596708granisetronConfirmed FDA, Wikidata
- NCI Thesaurus C62031GranisetronConfirmed FDA, Wikidata
- DrugBank DB00889One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017829 | Granisetron | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | WZG3J2MCOL | GRANISETRON | Confirmed FDA, Wikidata |
| RxNorm | 26237 | — | Confirmed FDA, Wikidata |
| Wikidata | Q596708 | granisetron | Confirmed FDA, Wikidata |
| NCI Thesaurus | C62031 | Granisetron | Confirmed FDA, Wikidata |
| DrugBank | DB00889 | — | One source Wikidata |
Also registered as granisetron hydrochloride (UNII 318F6L70J8 · RxNorm 142149).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.